The Latest Breaking News from VERU

Data Committee Recommends Veru's COVID-19 Trial To Continue Unmodified

The Independent Data Monitoring Committee (IDMC) has 

Benzinga · Feb 14, 2022

Veru Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Veru (NASDAQ:VERU) reported Q1 sales of $14.13 million. Earnings fell to a loss of $6.38 million, resulting in a 48.56% decrease from last quarter.

Benzinga · Feb 10, 2022

Veru Q1 Earnings Top Estimates

Veru Inc (NASDAQ:VERU) reported a first-quarter FY22 sales decline of 3% year-on-year, to $14.13 million, beating the analyst consensus of $13 million. U.S. FC2 prescription net revenues climbed 27% Y/Y to $11.6 million. Gross profit rose 9% to $11.8 million, while the margin expanded 1000 basis points Y/Y to 84%. The operating loss…

Benzinga · Feb 9, 2022